Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiaki Iba

Showing results (1-10 of 274) with videos related to

Pageof 28
Sort By:
Critical Care Medicine|February 19, 2014
The obstacles that should be overcome to develop new anticoagulants for severe sepsisToshiaki Iba
Critical Care (London, England)|May 24, 2015
Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulationToshiaki Iba
Thrombosis Research|February 7, 2012
The meanings of DIC diagnostic criteriaToshiaki Iba,
Blood Transfusion = Trasfusione Del Sangue|November 5, 2014
Controversies regarding the use of antithrombin for sepsis-associated disseminated intravascular coagulation: an update of the evidenceToshiaki Iba
Critical Care (London, England)|September 29, 2016
Bleeding complications of anticoagulant therapy in sepsis-induced disseminated intravascular coagulationToshiaki Iba
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 16, 2008
[Pretreatment with cilostazol protects against the vascular endothelial damage after ischemia/reperfusion]Toshiaki Iba
Juntendo Medical Journal|September 19, 2025
History of Disseminated Intravascular Coagulation (DIC) Research and My Personal Research HistoryToshiaki Iba
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 17, 2003
[Disseminated intravascular coagulation]Toshiaki Iba, Akio Kidokoro
Journal of Immunology Research|July 11, 2015
Kinetics of Circulating Damage-Associated Molecular Patterns in SepsisTakahiro Miki, Toshiaki Iba
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2004
[Activated protein C (the impact of PROWESS trial)]Toshiaki Iba, Akio Kidokoro
Pageof 28

Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
Critical Care Medicine|February 19, 2014
The obstacles that should be overcome to develop new anticoagulants for severe sepsisToshiaki Iba
Critical Care (London, England)|May 24, 2015
Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulationToshiaki Iba
Thrombosis Research|February 7, 2012
The meanings of DIC diagnostic criteriaToshiaki Iba,
Blood Transfusion = Trasfusione Del Sangue|November 5, 2014
Controversies regarding the use of antithrombin for sepsis-associated disseminated intravascular coagulation: an update of the evidenceToshiaki Iba
Critical Care (London, England)|September 29, 2016
Bleeding complications of anticoagulant therapy in sepsis-induced disseminated intravascular coagulationToshiaki Iba
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 16, 2008
[Pretreatment with cilostazol protects against the vascular endothelial damage after ischemia/reperfusion]Toshiaki Iba
Juntendo Medical Journal|September 19, 2025
History of Disseminated Intravascular Coagulation (DIC) Research and My Personal Research HistoryToshiaki Iba
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 17, 2003
[Disseminated intravascular coagulation]Toshiaki Iba, Akio Kidokoro
Journal of Immunology Research|July 11, 2015
Kinetics of Circulating Damage-Associated Molecular Patterns in SepsisTakahiro Miki, Toshiaki Iba
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2004
[Activated protein C (the impact of PROWESS trial)]Toshiaki Iba, Akio Kidokoro
Pageof 28